Why is Tatva Chintan falling/rising?

As of 17-Sep, Tatva Chintan Pharma Chem Ltd is currently priced at Rs 1,103.90, reflecting a decrease of Rs 2.2 or 0.2%. The stock has recently experienced a trend reversal, falling after four consecutive days of gains. Despite this decline, it has outperformed the market over various periods, showing a 10.96% return over the past year compared to the Sensex's negative return of -0.46%. Additionally, the stock is trading above its moving averages across multiple time frames, indicating a generally positive trend. The significant increase in delivery volume, which rose by 301.49% against the 5-day average, suggests rising investor participation, although today's performance underperformed the sector by 1.19%.
In the broader market context, Tatva Chintan's recent performance contrasts with the BSE500, which has generated negative returns of -2.63% over the last year. The stock's ability to maintain a positive return in a declining market highlights its resilience. However, the current decline may be attributed to profit-taking after a strong upward movement, as indicated by the recent trend reversal. Overall, while the stock has shown strong performance relative to the market, the short-term fluctuations reflect typical market behavior following a period of gains.